Spire Wealth Management lessened its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities & Exchange ...
Edwards Lifesciences Corp. closed 26.14% below its 52-week high of $96.12, which the company reached on March 28th.
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...
22h
Zacks.com on MSNBD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin UpBecton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...
23h
Zacks.com on MSNDexCom (DXCM) Q4 Earnings Preview: What's in the Cards?Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results